Instrumentarium gets FDA OK on breast system

Article

The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.The newly

The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.

The newly approved items are part of Instrumentarium's Diamond Breast Care System. The stereotactic feature can image from any two angles, which gives it flexibility and saves procedure time. Although the system is film-based, an amorphous selenium full-field digital upgrade kit is in the works. n

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.